BRTX Biorestorative Therapies
- 1.700
- +0.050+3.03%
Biorestorative Therapies News
Express News | BioRestorative Therapies Announces Notice Of Allowance For Patent Related To Its ThermoStem Platform
Express News | BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of Thermostem® Metabolic Disease Program
Express News | BioRestorative Therapies Shares Are Trading Higher After the Company Announced It Regained Compliance With the Nasdaq
What's Going On With BioRestorative Therapies Stock?
BioRestorative Therapies, Inc. (NASDAQ:BRTX) shares are trading higher Monday after the company announced it has received notice from the Nasdaq Stock Market that it has regained compliance with listi
Express News | BioRestorative Therapies Regains Compliance With Nasdaq Listing Rule
Express News | BioRestorative Therapies Q1 Net Income USD -2.2 Million
Express News | BioRestorative Therapies Q1 Operating Income USD -4.1 Million
Express News | BioRestorative Therapies Regains Compliance With Nasdaq Listing Rule 5250(C)(1); Reports First Quarter 2024 Financial Results
Maxim Group Maintains Biorestorative Therapies(BRTX.US) With Buy Rating, Maintains Target Price $6
Maxim Group analyst Michael Okunewitch maintains $Biorestorative Therapies(BRTX.US)$ with a buy rating, and maintains the target price at $6.According to TipRanks data, the analyst has a success rate
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Signet Jewelers Limited (NYSE:SIG) fell sharply during Thursday's session following mixed first-quarter earnings including an 8.9% drop in same store sales.The company reported a first-quart
Top Midday Gainers
BioRestorative Therapies (BRTX) rallied past 32% amid heavy trading after the company said Thursday it is in "substantive" licensing talks for its off-the-shelf metabolic intellectual property. More t
Gold Down 1%; Broadcom Shares Jump After Upbeat Results
U.S. stocks traded mixed midway through trading, with the Dow Jones index dipping by more than 200 points on Thursday.The Dow traded down 0.60% to 38,481.44 while the NASDAQ rose 0.31% to 17,663.22. T
Why BioRestorative Therapies Stock Is Moving Higher Thursday
BioRestorative Therapies, Inc. (NASDAQ:BRTX) shares are trading higher Thursday after the company said it has engaged in licensing discussions with a undisclosed commercial regenerative medicine compa
Shares of This Biotech Surge on Licensing Talks
BioRestorative (BRTX) Sees Significant Stock Surge Amid Licensing Talks
As news of substantial negotiations for a potential licensing agreement surfaced, shares of BioRestorative Therapies, Inc. (NASDAQ: BRTX) have surged on the US stock charts. At the latest check during the current market session, BRTX stock was trading up 62.55%, reaching $2.17. Progress In Regenerative Medicine BioRestorative (BRTX) said today that it has entered into ...
Market Mover | BioRestorative Therapies Soars 40% As the Company is in Talks for ThermoStem® Metabolic Disease Program License
The company announced that it has held discussions with a commercial stage regenerative medicine company regarding its allogeneic, off-the-shelf ThermoStem metabolic intellectual property.
Dow Tumbles Over 100 Points; US Producer Prices Decline In May
U.S. stocks traded mixed this morning, with the Dow Jones index falling by more than 100 points on Thursday.Following the market opening Thursday, the Dow traded down 0.36% to 38,574.00 while the NASD
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
Health care stocks were mixed pre-bell Thursday, with the Health Care Select Sector SPDR Fund (XLV) down 0.5% and the Health Care Select Sector SPDR Fund (XLV) up 0.8%. BioRestorative Therapies (BRTX)
Sector Update: Health Care
Health care stocks were edging higher pre-bell Thursday with the Health Care Select Sector SPDR Fund (XLV) up 0.6% and the Health Care Select Sector SPDR Fund (XLV) recently advancing by 0.6%. BioRest
BioRestorative Therapies in Licensing Talks for Metabolic Disease Program
BioRestorative Therapies (BRTX) said Thursday it is in "substantive" licensing talks for its off-the-shelf metabolic intellectual property.
Analysis
Price Target
No Data
